Refresh

Dr. Reddy's Laboratories Ltd.

Price on BSE   13 Feb,15:29 LIVE
1,268.60
-5.95
(-0.47%)

© 2026 Rediff.com
  • Volume :
  • 17,370.00
  • Prev Close :
  • 1,274.55
  • Day's H/L (Rs.) :
  • 1,279.00 - 1,264.20
  • 52wk H/L (Rs.) :
  • 1,377.95 - 1,025.90
  • Mkt Cap (Rs. Cr) :
  • 105,877.36
Price on NSE   13 Feb,15:57 LIVE
1,268.10
-6.80
(-0.53%)

© 2026 Rediff.com
  • Volume :
  • 838,946.00
  • Prev Close :
  • 1,274.90
  • Day's H/L (Rs.) :
  • 1,279.30 - 1,263.60
  • 52wk H/L (Rs.) :
  • 1,379.70 - 1,020.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Non-US uptick seen driving gains for Dr Reddy's Labs
Rediff.com   23 Jan 2026
Dr Reddy's profit down 14% on low Lenalidomide US sales
Rediff.com   22 Jan 2026
Domestic sales a booster dose for pharma revenues
Rediff.com   19 Jan 2026
'India Should Move Quickly As Conditions Change'
Rediff.com   02 Jan 2026
Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com   22 Dec 2025
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
19.87
EPS (Rs.)
64.14
Sales (Rs. Cr)
4,282.70
Face Value (Rs.)
1
Net Profit Margin(%)
23.14
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
18.53

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Q3 Profit Dips 14% to Rs 1,210 Cr
Dr Reddy''s Q3FY26 profit declines 14% to Rs 1,210 crore due to lower US sales. Revenue rises to Rs 8,727 crore. India sales up 19%.
Jan 21, 2026 18:20
Dr Reddy''s & Immutep Ink Cancer Drug Licensing Pact
Dr Reddy''s and Immutep collaborate to develop and commercialize Eftilagimod Alfa (Efti), a cancer medication, outside key markets.
Dec 08, 2025 14:49
Dr Reddy''s Biosimilar Approved in Europe
Dr Reddy''s gets EU nod for AVT03, a biosimilar of Prolia (denosumab) and Xgeva, used to treat osteoporosis and prevent bone complications.
Nov 24, 2025 17:22
Dr Reddy''s Srikakulam Unit Gets USFDA VAI
Dr Reddy''s Srikakulam facility gets Voluntary Action Indicated (VAI) status from USFDA after inspection. Inspection officially closed.
Oct 21, 2025 12:46
Glenmark, Dr Reddy''s Recall Products in US: USFDA
Glenmark and Dr Reddy''s recall products in the US due to manufacturing issues, says USFDA. Recalls include oral contraceptives and muscle relaxants.
Oct 19, 2025 10:20

More News for Dr. Reddy's Laboratories Ltd. »

News for Pharmaceuticals and health care

Pension Funds & Health Cover Bundling: PFRDA Chief
PFRDA chief reveals 3 pension funds exploring bundled pension & health cover plans. Aim: medical expense savings & better healthcare deals.
Feb 13, 2026 20:25
Stock Market Tumble: Investors Lose Rs 7.02 Lakh Cr
Indian stock markets tumble, eroding investors' wealth by Rs 7.02 lakh crore. Sensex falls 1048 points amid global selloff.
Feb 13, 2026 20:08
RBI to Allow Bank Loans to REITs by July 1
RBI proposes allowing banks to lend to REITs (Real Estate Investment Trusts) by July 1, capping exposure at 49% of asset value.
Feb 13, 2026 20:02
Heritage Foods Denies Tirumala Ghee Link
Heritage Foods refutes allegations of supplying ghee to Tirumala Temple, threatens defamation case against YSRCP leaders.
Feb 13, 2026 19:54
Livestock Sector Gets Agriculture Status in Maharashtra
Maharashtra grants agriculture status to livestock, boosting rural entrepreneurship. Expo highlights new technologies and breeds.
Feb 13, 2026 19:49

More News »

Top News

Pension Funds & Health Cover Bundling: PFRDA Chief
PFRDA chief reveals 3 pension funds exploring bundled pension & health cover plans. Aim: medical expense savings & better healthcare deals.
Feb 13, 2026 20:25
MUFG Directors on Shriram Finance Board
MUFG proposes two directors for Shriram Finance board after acquiring 20% stake. RBI approval awaited for the appointments.
Feb 13, 2026 20:14
Stock Market Tumble: Investors Lose Rs 7.02 Lakh Cr
Indian stock markets tumble, eroding investors' wealth by Rs 7.02 lakh crore. Sensex falls 1048 points amid global selloff.
Feb 13, 2026 20:08
India Tech M-Cap to Hit 10% in 10 Years: Kunal Bahl
Kunal Bahl predicts new-age tech firms will comprise 8-10% of India's listed market cap in 10 years, driven by digitization.
Feb 13, 2026 20:04
RBI to Allow Bank Loans to REITs by July 1
RBI proposes allowing banks to lend to REITs (Real Estate Investment Trusts) by July 1, capping exposure at 49% of asset value.
Feb 13, 2026 20:02

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com